InVivoMAb anti-mouse/human VLA-4 (CD49d)(Clone PS/2)
(InVivoMAb anti-mouse/human VLA-4 (CD49d)产品图)
产品详情:
产品货号 | |
产品规格 | 1/5/25/50/100mg |
抗体亚型 | Rat IgG2b, κ |
推荐同型对照 | InVivoMAb rat IgG2b isotype control, anti-keyhole limpet hemocyanin(货号:BE0090) |
推荐抗体稀释液 | InVivoPure™ pH 6.5 Dilution Buffer(货号:IP0065) |
免疫原 | Mouse P815 mast cells |
应用 | in vivo VLA-4 neutralization in vitro VLA-4 neutralization Flow cytometry |
产品形式 | PBS , pH 6.5 Contains no stabilizers or preservatives |
内毒素水平 | <2EU/mg (<0.002EU/μg) 使用 LAL gel clotting 测定 |
纯度 | >95% Determined by SDS-PAGE |
无菌处理 | 0.2 μM filtered |
生产形式 | 从组织培养上清液中纯化得到。 |
纯化形式 | Protein G |
RRID | AB_1107657 |
分子量大小 | 150 kDa |
保存条件 | 抗体原溶液应保存在4°C条件下,不要冷冻保存。 |
已发表参考文献:
in vivo VLA-4 neutralization | Badell, I. R., et al. (2015). “Pathogen Stimulation History Impacts Donor-Specific CD8 T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.” Am J Transplant. |
in vivo VLA-4 neutralization | Guidotti, L. G., et al. (2015). “Immunosurveillance of the liver by intravascular effector CD8(+) T cells.” Cell 161(3): 486-500. |
Flow cytometry | Wang, X., et al. (2014). “Integrin-mediated interactions between B cells and follicular dendritic cells influence germinal center B cell fitness.” J Immunol 192(10): 4601-4609. |
详情请咨询 BioXcell 中国授权代理-欣博盛生物
全国服务热线: 4006-800-892 邮箱: market@hnyazd.com
深圳: 0755-26755892 北京: 010-88594029 上海: 021-34613729
广州:020-87615159 香港: 852-69410778
代理品牌网站: www.hnyazd.com
自主品牌网站: www.neobiosescience.net